Expressional and prognostic value of<scp>HPCAL1</scp>in cholangiocarcinoma via integrated bioinformatics analyses and experiments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expressional and prognostic value ofHPCAL1in cholangiocarcinoma via integrated bioinformatics analyses and experiments

Published:2022-05-29 Issue:1 Volume:12 Page:824-836
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Ma Mingjian¹,Zeng Guangyan¹²,Li Jinhui³,Liang Jiahua¹,Huang Li¹,Chen Jiancong¹^ORCID,Lai Jiaming¹

Affiliation:

1. Department of Pancreato‐Biliary Surgery First Affiliated Hospital, Sun Yat‐Sen University Guangzhou PR China

2. Department of Gastrointestinal Surgery Eighth Affiliated Hospital, Sun Yat‐sen University Shenzhen PR China

3. Department of Pharmacology and Experimental Therapeutics Boston University School of Medicine Boston Massachusetts USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4897

Reference40 articles.

1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade

3. Pathogenesis of Cholangiocarcinoma

4. Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma

5. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance;Oncogene;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3